Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment

Published:2024-11 Issue:25 Volume:42 Page:126184
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Augello Matteo,Wagenhäuser Isabell,Krone Manuel,Dauby Nicolas,Ferrara Pietro,Sabbatucci Michela,Ruta Simona,Rezahosseini Omid,Velikov Petar,Gkrania-Klotsas Effrossyni,Montes Jose,Franco-Paredes Carlos,Goodman Anna L.,Küçükkaya Sertaç,Tuells Jose,Harboe Zitta Barrella,Epaulard Olivier

Publisher

Elsevier BV

Reference69 articles.

1. Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA bivalent booster;Davis-Gardner;N Engl J Med,2023

2. Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 omicron variant;Lyke;Cell Rep Med,2022

3. Durability of immune responses to mRNA booster vaccination against COVID-19;Arunachalam;J Clin Invest,2023

4. Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden;Marking;Lancet Infect Dis,2024

5. SARS-CoV-2 S-RBD IgG & Neutralizing antibodies among different categories of health care workers post third dose BNT162b2 mRNA COVID-19 vaccine;Wan Shuaib;Hum Vaccin Immunother,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP